US 12138247
Non-sedating dexmedetomidine treatment regimens
granted A61KA61K31/4174A61K47/38
Quick answer
US patent 12138247 (Non-sedating dexmedetomidine treatment regimens) held by BioXcel Therapeutics, Inc. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioXcel Therapeutics, Inc.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4174, A61K47/38, A61K9/006, A61P